New Threads Only:  Add to Google Reader or Homepage
New Threads & Replies:  Add to Google Reader or Homepage
Forums are for serious investors only. GuruFocus Forum Rules.

Forum List » Business News and Headlines
SEC Filings, Earing Reports, Press Releases
New Topic Search
Goto Thread: PreviousNext
Goto: Forum ListMessage ListNew TopicSearchLog In
BioMarin Pharmaceutical Inc. (BMRN) CEO Jean Jacques Bienaime sells 20,000 Shares
Posted by: gurufocus (IP Logged)
Date: May 4, 2012 05:25PM

CEO of BioMarin Pharmaceutical Inc. (BMRN) Jean Jacques Bienaime sells 20,000 shares of BMRN on 05/04/2012 at an average price of $36.34 a share.

Biomarin Pharma has a market cap of $4.08 billion; its shares were traded at around $35.79 with and P/S ratio of 9.3.

CEO Recent Trades:


  • CEO Jean Jacques Bienaime sold 30,000 shares of BMRN stock on 05/02/2012 at the average price of 35.24. Jean Jacques Bienaime owns at least 113,191 shares after this. The price of the stock has increased by 1.56% since.
  • CEO Jean Jacques Bienaime sold 22,000 shares of BMRN stock on 04/27/2012 at the average price of 34.99. Jean Jacques Bienaime owns at least 112,093 shares after this. The price of the stock has increased by 2.29% since.
  • CEO Jean Jacques Bienaime sold 15,000 shares of BMRN stock on 03/09/2012 at the average price of 34.46. Jean Jacques Bienaime owns at least 114,093 shares after this. The price of the stock has increased by 3.86% since.
  • CEO Jean Jacques Bienaime sold 1,000 shares of BMRN stock on 03/08/2012 at the average price of 35. Jean Jacques Bienaime owns at least 114,093 shares after this. The price of the stock has increased by 2.26% since.
  • CEO Jean Jacques Bienaime sold 1,000 shares of BMRN stock on 02/29/2012 at the average price of 36.26. Jean Jacques Bienaime owns at least 115,093 shares after this. The price of the stock has decreased by 1.3% since.

CFO Recent Trades:


  • SVP, CFO Jeffrey H Cooper sold 83,036 shares of BMRN stock on 02/24/2012 at the average price of 35.07. Jeffrey H Cooper owns at least 40,104 shares after this. The price of the stock has increased by 2.05% since.
  • SVP, CFO Jeffrey H Cooper sold 2,500 shares of BMRN stock on 01/03/2012 at the average price of 34.75. Jeffrey H Cooper owns at least 40,104 shares after this. The price of the stock has increased by 2.99% since.

Directors and Officers Recent Trades:


  • EVP, Chief Medical Officer Henry J Fuchs sold 5,000 shares of BMRN stock on 05/01/2012 at the average price of 34.99. Henry J Fuchs owns at least 30,018 shares after this. The price of the stock has increased by 2.29% since.
  • VP, Human Resources Mark Wood sold 1,853 shares of BMRN stock on 04/23/2012 at the average price of 34.54. Mark Wood owns at least 20,634 shares after this. The price of the stock has increased by 3.62% since.
  • EVP, Chief Medical Officer Henry J Fuchs sold 7,691 shares of BMRN stock on 04/20/2012 at the average price of 35. Henry J Fuchs owns at least 28,920 shares after this. The price of the stock has increased by 2.26% since.
  • EVP, Chief Medical Officer Henry J Fuchs sold 5,000 shares of BMRN stock on 04/02/2012 at the average price of 34.08. Henry J Fuchs owns at least 36,611 shares after this. The price of the stock has increased by 5.02% since.
  • VP, Human Resources Mark Wood sold 1,855 shares of BMRN stock on 03/22/2012 at the average price of 35.65. Mark Wood owns at least 20,634 shares after this. The price of the stock has increased by 0.39% since.


For the complete insider trading history of BMRN, click here.


Stocks Discussed: BMRN,
Rate this post:




Sorry, only registered users may post in this forum.

Please Login if you have an account or Create a Free Account if you don't




Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial